Quantitative proteomics reveals the protective effects of Yinchenzhufu decoction against cholestatic liver fibrosis in mice by inhibiting the PDGFRβ/PI3K/AKT pathway.

Authors:
Meng Q; Zhu H; Li Y; Peng X; Wang T and 6 more

Journal:
Front Pharmacol

Publication Year: 2024

DOI:
10.3389/fphar.2024.1341020

PMCID:
PMC10926276

PMID:
38469403

View on PubMed View on PMC View Publisher

Journal Information

Journal Title: Front Pharmacol

Detailed journal information not available.

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score

3/6

50.0% Transparent

Transparency Indicators

Click on green indicators to view evidence text

Core Indicators

Data Sharing

Code Sharing

COI Disclosure

Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Funding Disclosure

Evidence found in paper:

"The authors declare financial support was received for the research, authorship, and/or publication of this article. This study is funded by the National Natural Science Foundation of China (No. 81773871) and SIMM-SHUTCM Traditional Chinese Medicine Innovation Joint Research Program (Grant No. E2G804H)."

Protocol Registration

Open Access

Paper is freely available to read

Additional Indicators

Replication

Novelty Statement

Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025